Pub Date : 2024-09-01DOI: 10.1016/j.explore.2024.103045
Amrita Bonthu
{"title":"Cranberries for preventing urinary tract infections: Summary of a Cochrane review","authors":"Amrita Bonthu","doi":"10.1016/j.explore.2024.103045","DOIUrl":"10.1016/j.explore.2024.103045","url":null,"abstract":"","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103045"},"PeriodicalIF":1.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1550830724001526/pdfft?md5=1b4f4d8d1c63ed820ff6c50d3870a103&pid=1-s2.0-S1550830724001526-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142239284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-01DOI: 10.1016/S1550-8307(24)00158-7
{"title":"Masthead page","authors":"","doi":"10.1016/S1550-8307(24)00158-7","DOIUrl":"10.1016/S1550-8307(24)00158-7","url":null,"abstract":"","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 5","pages":"Article 103051"},"PeriodicalIF":1.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142136292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-23DOI: 10.1016/j.explore.2024.103043
Wan-Ting Soong , Shih-Ying Sung , Sunny Jui-Shan Lin
Introduction
Patients with end-stage heart failure have limited options for medical treatment, and this ultimately necessitates heart transplantation. Patients undergoing heart transplant surgery are burdened with substantial costs related to finances, procedural risks, and postoperative quality of life. This report presents a case of heart failure in a patient whose limbs and heart were preserved through a collaboration between modern and traditional Chinese medicine (TCM).
Patient Presentation
A 47-year-old man was admitted to the emergency department with out-of-hospital cardiac arrest (OHCA) and was diagnosed with 3-vessel disease and acute decompensated heart failure on October 27, 2020. After extracorporeal membrane oxygenation (ECMO), the patient presented with cyanosis and gangrene in all four limbs. Cardiologists and plastic surgeons recommended heart transplantation and amputation. The patient wanted to keep his limbs and heart intact and requested to receive TCM. A TCM physician was consulted by visiting staff to provide combined care. After TCM intervention, both the ejection fraction (EF) and gangrene improved. Until now, the patient continues to receive TCM treatment, lives with preserved limbs and heart, and went through SARS-CoV2 infection smoothly in 2023.
Conclusion
TCM met the expectations of the patient and reduced the high medical expenses. This approach may improve the outlook and be a more economical option for patients with end-stage heart failure.
{"title":"A patient with out-of-hospital cardiac arrest saved from heart transplantation and amputation through a collaboration between modern and traditional Chinese medicine: A case report","authors":"Wan-Ting Soong , Shih-Ying Sung , Sunny Jui-Shan Lin","doi":"10.1016/j.explore.2024.103043","DOIUrl":"10.1016/j.explore.2024.103043","url":null,"abstract":"<div><h3>Introduction</h3><p>Patients with end-stage heart failure have limited options for medical treatment, and this ultimately necessitates heart transplantation. Patients undergoing heart transplant surgery are burdened with substantial costs related to finances, procedural risks, and postoperative quality of life. This report presents a case of heart failure in a patient whose limbs and heart were preserved through a collaboration between modern and traditional Chinese medicine (TCM).</p></div><div><h3>Patient Presentation</h3><p>A 47-year-old man was admitted to the emergency department with out-of-hospital cardiac arrest (OHCA) and was diagnosed with 3-vessel disease and acute decompensated heart failure on October 27, 2020. After extracorporeal membrane oxygenation (ECMO), the patient presented with cyanosis and gangrene in all four limbs. Cardiologists and plastic surgeons recommended heart transplantation and amputation. The patient wanted to keep his limbs and heart intact and requested to receive TCM. A TCM physician was consulted by visiting staff to provide combined care. After TCM intervention, both the ejection fraction (EF) and gangrene improved. Until now, the patient continues to receive TCM treatment, lives with preserved limbs and heart, and went through SARS-CoV2 infection smoothly in 2023.</p></div><div><h3>Conclusion</h3><p>TCM met the expectations of the patient and reduced the high medical expenses. This approach may improve the outlook and be a more economical option for patients with end-stage heart failure.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103043"},"PeriodicalIF":1.9,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142089136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-21DOI: 10.1016/j.explore.2024.103041
Fatemeh sadat Hasheminasab , Maryam Azimi
The initial descriptions of inflammatory bowel disease (IBD) have been a topic of discussion. Cases of persistent diarrhea have been documented as far back as ancient Greece, with even Hippocrates (∼ 460–370 BCE) exploring various potential causes of diarrhea. Persian medicine was the predominant medical practice in the Eurasia region until the 18th century and had roots in Hippocrates and the ancient civilization of the region. Scholars, such as Avicenna (980–1025 CE), extensively described a disease characterized by intestinal ulcers, bloody diarrhea, and abdominal pain in the early medieval period. While some of the definitions and etiologies of IBD in Persian medicine are based on humoral theories that differ from current medical concepts, recent studies have suggested a potential relationship between the traditional Persian medicine understanding of the disease and IBD. Persian medicine classifies patients with specific diseases into different types of disorders known as dystemperament, with the application of these differences referred to as "syndrome differentiation." These traditional classifications require distinct therapeutic approaches. Research has delved into the molecular bases of the humoral theory and the impact of syndrome differentiation on drug selection for patients, including those with IBD. However, further research is needed to explore the potential effectiveness of Persian medicine in treating IBD and to understand how this ancient classification system can contribute to improved disease management.
{"title":"A review of inflammatory bowel disease from the perspective of Persian medicine","authors":"Fatemeh sadat Hasheminasab , Maryam Azimi","doi":"10.1016/j.explore.2024.103041","DOIUrl":"10.1016/j.explore.2024.103041","url":null,"abstract":"<div><p>The initial descriptions of inflammatory bowel disease (IBD) have been a topic of discussion. Cases of persistent diarrhea have been documented as far back as ancient Greece, with even Hippocrates (∼ 460–370 BCE) exploring various potential causes of diarrhea. Persian medicine was the predominant medical practice in the Eurasia region until the 18th century and had roots in Hippocrates and the ancient civilization of the region. Scholars, such as Avicenna (980–1025 CE), extensively described a disease characterized by intestinal ulcers, bloody diarrhea, and abdominal pain in the early medieval period. While some of the definitions and etiologies of IBD in Persian medicine are based on humoral theories that differ from current medical concepts, recent studies have suggested a potential relationship between the traditional Persian medicine understanding of the disease and IBD. Persian medicine classifies patients with specific diseases into different types of disorders known as dystemperament, with the application of these differences referred to as \"syndrome differentiation.\" These traditional classifications require distinct therapeutic approaches. Research has delved into the molecular bases of the humoral theory and the impact of syndrome differentiation on drug selection for patients, including those with IBD. However, further research is needed to explore the potential effectiveness of Persian medicine in treating IBD and to understand how this ancient classification system can contribute to improved disease management.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103041"},"PeriodicalIF":1.9,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142146753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-21DOI: 10.1016/j.explore.2024.103040
Sifu Ha , Xiaoyu Song
Objective
To evaluate the effect of berberine as adjuvant therapy for the treatment of reduced fertility potential in women with polycystic ovary syndrome (PCOS) through a meta-analysis.
Methods
We comprehensively searched CNKI, SinoMed, Wanfang, Cochrane Library, PubMed, Embase databases to identify randomized controlled trials (RCTs) evaluating the effect of berberine as adjuvant therapy for treating reduced fertility potential in women with PCOS.
Results
A total of 10 RCTs involving 713 patients were included. Berberine in combination with Western medicine significantly improved endometrial thickness (weight mean difference [WMD] 1.62 mm; 95 % confidence interval [CI] 1.39–1.85), ovulation rate (risk ratio [RR] 1.41; 95 % CI 1.26–1.60), and clinical pregnancy rate (RR 1.96; 95 % CI 1.59–2.41) compared to Western medicine alone. Moreover, berberine as adjuvant therapy also significantly reduced the blood levels of luteinizing hormone (WMD -2.07 U/L; 95 % CI -2.62 to -1.51) and total testosterone (standard mean difference -0.70; 95 % CI -1.02 to -0.39) but not the level of follicle-stimulating hormone level (WMD -0.23 IU/L; 95 % CI -0.52 to 0.06).
Conclusions
Berberine may serve as an adjuvant therapy to enhance ovulation and increase clinical pregnancy rates in women with PCOS. The potential advantages of berberine may be linked to improvements in endometrial thickness, total testosterone, and luteinizing hormone level. However, further clinical trials are needed to confirm these findings and establish definitive conclusions.
方法 我们全面检索了CNKI、SinoMed、Wanfang、Cochrane Library、PubMed、Embase等数据库,以确定评估小檗碱作为辅助疗法治疗多囊卵巢综合征(PCOS)女性生育力下降效果的随机对照试验(RCT)。结果 共纳入10项RCT,涉及713例患者。与单独使用西药相比,小檗碱与西药联合使用可显著改善子宫内膜厚度(重量平均差 [WMD] 1.62 mm; 95 % 置信区间 [CI] 1.39-1.85)、排卵率(风险比 [RR] 1.41; 95 % CI 1.26-1.60)和临床妊娠率(RR 1.96; 95 % CI 1.59-2.41)。此外,小檗碱作为辅助疗法还能显著降低血中黄体生成素水平(WMD -2.07 U/L;95 % CI -2.62 to -1.51 )和总睾酮水平(标准平均差 -0.70 ;95 % CI -1.02 to -0.结论小檗碱可作为一种辅助疗法,促进多囊卵巢综合征妇女的排卵并提高临床妊娠率。小檗碱的潜在优势可能与子宫内膜厚度、总睾酮和黄体生成素水平的改善有关。不过,还需要进一步的临床试验来证实这些发现并得出明确的结论。
{"title":"Berberine as adjuvant therapy for treating reduced fertility potential in women with polycystic ovary syndrome: A meta-analysis of randomized controlled trials","authors":"Sifu Ha , Xiaoyu Song","doi":"10.1016/j.explore.2024.103040","DOIUrl":"10.1016/j.explore.2024.103040","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the effect of berberine as adjuvant therapy for the treatment of reduced fertility potential in women with polycystic ovary syndrome (PCOS) through a meta-analysis.</p></div><div><h3>Methods</h3><p>We comprehensively searched CNKI, SinoMed, Wanfang, Cochrane Library, PubMed, Embase databases to identify randomized controlled trials (RCTs) evaluating the effect of berberine as adjuvant therapy for treating reduced fertility potential in women with PCOS.</p></div><div><h3>Results</h3><p>A total of 10 RCTs involving 713 patients were included. Berberine in combination with Western medicine significantly improved endometrial thickness (weight mean difference [WMD] 1.62 mm; 95 % confidence interval [CI] 1.39–1.85), ovulation rate (risk ratio [RR] 1.41; 95 % CI 1.26–1.60), and clinical pregnancy rate (RR 1.96; 95 % CI 1.59–2.41) compared to Western medicine alone. Moreover, berberine as adjuvant therapy also significantly reduced the blood levels of luteinizing hormone (WMD -2.07 U/L; 95 % CI -2.62 to -1.51) and total testosterone (standard mean difference -0.70; 95 % CI -1.02 to -0.39) but not the level of follicle-stimulating hormone level (WMD -0.23 IU/L; 95 % CI -0.52 to 0.06).</p></div><div><h3>Conclusions</h3><p>Berberine may serve as an adjuvant therapy to enhance ovulation and increase clinical pregnancy rates in women with PCOS. The potential advantages of berberine may be linked to improvements in endometrial thickness, total testosterone, and luteinizing hormone level. However, further clinical trials are needed to confirm these findings and establish definitive conclusions.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103040"},"PeriodicalIF":1.9,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142135911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Indigenous communities across Canada persist at the forefront of environmental and climate-related challenges, necessitating a concerted effort to integrate traditional Indigenous land-based knowledge and practices that inherently promote environmental protection and resilience. Using a decolonial feminist theoretical framework, this research centers on Indigenous community perspectives on the climate crisis and their land-based adaptions. Such an approach empowers Indigenous communities to reclaim agency over their narratives and shape research agendas congruent with their lived realities and aspirations. The study concludes by promoting the imperative of revitalizing traditional Indigenous land-based knowledge, practices and relationships with their ancestral lands. Despite emerging recognition within the scientific literature and international agreements, such as the Paris Agreement, of the significance of traditional Indigenous land-based knowledge, many climate mitigation and adaptation initiatives continue to overlook Indigenous participation at various decision-making junctures. Hence, this paper advocates the necessity for international frameworks to acknowledge and integrate traditional knowledge systems and Indigenous participation across national borders, fostering inclusive climate crisis solutions that resonate with Indigenous communities' perspectives and experiences.
{"title":"Indigenous land-based practices for climate crisis adaptions","authors":"Ranjan Datta , Jebunnessa Chapola , Kara Owen , Margot Hurlbert , Audra Foggin","doi":"10.1016/j.explore.2024.103042","DOIUrl":"10.1016/j.explore.2024.103042","url":null,"abstract":"<div><p>Indigenous communities across Canada persist at the forefront of environmental and climate-related challenges, necessitating a concerted effort to integrate traditional Indigenous land-based knowledge and practices that inherently promote environmental protection and resilience. Using a decolonial feminist theoretical framework, this research centers on Indigenous community perspectives on the climate crisis and their land-based adaptions. Such an approach empowers Indigenous communities to reclaim agency over their narratives and shape research agendas congruent with their lived realities and aspirations. The study concludes by promoting the imperative of revitalizing traditional Indigenous land-based knowledge, practices and relationships with their ancestral lands. Despite emerging recognition within the scientific literature and international agreements, such as the Paris Agreement, of the significance of traditional Indigenous land-based knowledge, many climate mitigation and adaptation initiatives continue to overlook Indigenous participation at various decision-making junctures. Hence, this paper advocates the necessity for international frameworks to acknowledge and integrate traditional knowledge systems and Indigenous participation across national borders, fostering inclusive climate crisis solutions that resonate with Indigenous communities' perspectives and experiences.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103042"},"PeriodicalIF":1.9,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1550830724001496/pdfft?md5=dfb8adc20c9fe670e5985865c75228ae&pid=1-s2.0-S1550830724001496-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142048088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Premenstrual syndrome (PMS) is a common disorder among female population that adversely affects their physical and emotional well-being. Conventional treatments for PMS may have limitations and side effects, prompting a need for complementary therapeutic approaches. This double-blind, randomized, placebo-controlled trial aimed to investigate the efficacy of individualized Homeopathic medicines (IH) in treating PMS symptoms in comparison to placebo (PL).
Methods
This study recruited female participants of reproductive age who had been experiencing premenstrual syndrome (PMS) for >3 months, from the Outpatient Department. The participants were randomly assigned to receive either IH or PL. The measured outcomes included the Shortened Premenstrual Assessment Form (SPAF) questionnaire as the primary outcome, and the Premenstrual Tension Syndrome Visual Analogue Scale (PMTS-VAS) and the Premenstrual Tension Syndrome Observer Rating Scale – Revised (PMTS-OR) as secondary outcomes. These measures were assessed at baseline and every month for 3 months.
Results
The results showed a statistically significant reduction in total SPAF scores for the IH group compared to the placebo group (F = 11.340; P < 0.001) at month 2 (-5.5 ± 1.8, P = 0.003), and month 3 (-6.6 ± 2.0, P = 0.002). Additionally, there were significant reductions in PMTS-VAS and PMTS-OR scores in the IH compared to placebo group. Natrum muriaticum (n = 4/30, 13.3 %) was the most frequently indicated medicines in the study. Four adverse events (13.33 %) occurred in the IH group, and six adverse events (16.67 %) in the Placebo group, with no serious events reported, and no additional medicinal treatment was required for participants during the study period.
Conclusions
Individualized Homeopathic medicines were found to be significantly effective, compared to placebo in reducing PMS symptoms. Further independent replication is warranted to validate and corroborate these findings, as well as to identify the most effective Homeopathic medicines for treating PMS symptoms. Until then, clinicians may consider these findings when exploring personalized and holistic therapeutic strategies for managing PMS.
{"title":"Individualized homeopathic medicines in the treatment of premenstrual syndrome: A double-blind, randomized, placebo-controlled trial","authors":"Sanjib Sahoo , Chintamani Nayak , Prasanta Rath , Soumya Bhattacharya , Suranjana Mukherjee , Abhijit Dutta","doi":"10.1016/j.explore.2024.103039","DOIUrl":"10.1016/j.explore.2024.103039","url":null,"abstract":"<div><h3>Introduction</h3><p>Background: Premenstrual syndrome (PMS) is a common disorder among female population that adversely affects their physical and emotional well-being. Conventional treatments for PMS may have limitations and side effects, prompting a need for complementary therapeutic approaches. This double-blind, randomized, placebo-controlled trial aimed to investigate the efficacy of individualized Homeopathic medicines (IH) in treating PMS symptoms in comparison to placebo (PL).</p></div><div><h3>Methods</h3><p>This study recruited female participants of reproductive age who had been experiencing premenstrual syndrome (PMS) for >3 months, from the Outpatient Department. The participants were randomly assigned to receive either IH or PL. The measured outcomes included the Shortened Premenstrual Assessment Form (SPAF) questionnaire as the primary outcome, and the Premenstrual Tension Syndrome Visual Analogue Scale (PMTS-VAS) and the Premenstrual Tension Syndrome Observer Rating Scale – Revised (PMTS-OR) as secondary outcomes. These measures were assessed at baseline and every month for 3 months.</p></div><div><h3>Results</h3><p>The results showed a statistically significant reduction in total SPAF scores for the IH group compared to the placebo group (<em>F</em> = 11.340; <em>P</em> < 0.001) at month 2 (-5.5 ± 1.8, <em>P</em> = 0.003), and month 3 (-6.6 ± 2.0, <em>P</em> = 0.002). Additionally, there were significant reductions in PMTS-VAS and PMTS-OR scores in the IH compared to placebo group. <em>Natrum muriaticum</em> (<em>n</em> = 4/30, 13.3 %) was the most frequently indicated medicines in the study. Four adverse events (13.33 %) occurred in the IH group, and six adverse events (16.67 %) in the Placebo group, with no serious events reported, and no additional medicinal treatment was required for participants during the study period.</p></div><div><h3>Conclusions</h3><p>Individualized Homeopathic medicines were found to be significantly effective, compared to placebo in reducing PMS symptoms. Further independent replication is warranted to validate and corroborate these findings, as well as to identify the most effective Homeopathic medicines for treating PMS symptoms. Until then, clinicians may consider these findings when exploring personalized and holistic therapeutic strategies for managing PMS.</p></div><div><h3>Trial Registration</h3><p>CTRI/2020/11/028,796, dt. 02/11/2020</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103039"},"PeriodicalIF":1.9,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142098822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-10DOI: 10.1016/j.explore.2024.103038
Hsuan-Ting Tang , Sheng-Teng Huang , Shi-Chen Ou
Introduction
Due to the continued threat to public health posed by SARS-CoV-2 and the ongoing emergence of novel variants, the integration of traditional Chinese medicine (TCM) with Western medicine provides a novel alternative management for critically ill patients.
Case presentation
This case report describes a 54-year-old male with severe COVID-19-associated acute respiratory distress syndrome (ARDS) who required extracorporeal membrane oxygenation (ECMO) support. Despite standard treatment, ECMO liberation was unsuccessful, and complications such as pneumothorax and hemothorax ensued. However, upon initiating combined TCM therapy on the 19th day of ECMO support, the patient exhibited gradual improvements in oxygenation and ventilation, leading to successful ECMO liberation on the 31st day.
Conclusion
This case underscores the potential of integrating TCM with conventional therapies for severe COVID-19 cases, offering a valuable treatment option amidst the evolving landscape of SARS-CoV-2 variants.
{"title":"Liberation from extracorporeal membrane oxygenation in a patient with severe COVID-19-associated acute respiratory distress syndrome using traditional Chinese medicine: A case report","authors":"Hsuan-Ting Tang , Sheng-Teng Huang , Shi-Chen Ou","doi":"10.1016/j.explore.2024.103038","DOIUrl":"10.1016/j.explore.2024.103038","url":null,"abstract":"<div><h3>Introduction</h3><p>Due to the continued threat to public health posed by SARS-CoV-2 and the ongoing emergence of novel variants, the integration of traditional Chinese medicine (TCM) with Western medicine provides a novel alternative management for critically ill patients.</p></div><div><h3>Case presentation</h3><p>This case report describes a 54-year-old male with severe COVID-19-associated acute respiratory distress syndrome (ARDS) who required extracorporeal membrane oxygenation (ECMO) support. Despite standard treatment, ECMO liberation was unsuccessful, and complications such as pneumothorax and hemothorax ensued. However, upon initiating combined TCM therapy on the 19th day of ECMO support, the patient exhibited gradual improvements in oxygenation and ventilation, leading to successful ECMO liberation on the 31st day.</p></div><div><h3>Conclusion</h3><p>This case underscores the potential of integrating TCM with conventional therapies for severe COVID-19 cases, offering a valuable treatment option amidst the evolving landscape of SARS-CoV-2 variants.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103038"},"PeriodicalIF":1.9,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142044627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-08DOI: 10.1016/j.explore.2024.103037
Yan Cao, Huihong Wu, Sujuan Shi, Dan Xie
Objective
To explore the effect of the mindfulness-based stress reduction (MBSR) practice on sleep quality and perceived stress in patients with spinal cord injury (SCI).
Method
A total of 104 patients with SCI (diagnosed via imaging and clinical symptoms) admitted to our hospital between January 2020 and December 2022 were selected as the study participants. The patients were randomly divided into two groups: the MBSR (observation) group and the control group. The observation group received MBSR therapy and routine nursing, and the control group received music training therapy and routine nursing. The Pittsburgh Sleep Quality Index (PSQI) was used to evaluate sleep quality, and the perceived stress score was used to evaluate stress experienced by the patients at three timepoints: before intervention, 4 weeks and 8weeks after intervention.
Results
Compared with before intervention, the PSQI scores of both the control group and intervention group participants significantly decreased after intervention(P < 0.01). Compared with the 4 weeks after intervention, the PSQI scores of both groups of participants decreased in the 8 weeks after intervention(P < 0.01). There was a significant difference in PSQI scores between the two groups of participants at 4 and 8 weeks after intervention(P < 0.01). Compared with before intervention, the average perceived stress score of both the control group and intervention group participants significantly decreased after intervention(P < 0.05). Compared with the 4 weeks after intervention, the average perceived stress score of both groups of participants decreased in the 8 weeks after intervention(P < 0.01). There was a significant difference in average perceived stress score between the two groups of participants at 4(P < 0.05) and 8 weeks(P < 0.01) after intervention(P < 0.01).
Conclusion
The use of MBSR therapy could effectively improve patient sleep quality and reduce perceived stress.
{"title":"Effects of mindfulness-based stress reduction therapy for sleep quality and perceived stress in patients with spinal cord injury","authors":"Yan Cao, Huihong Wu, Sujuan Shi, Dan Xie","doi":"10.1016/j.explore.2024.103037","DOIUrl":"10.1016/j.explore.2024.103037","url":null,"abstract":"<div><h3>Objective</h3><p>To explore the effect of the mindfulness-based stress reduction (MBSR) practice on sleep quality and perceived stress in patients with spinal cord injury (SCI).</p></div><div><h3>Method</h3><p>A total of 104 patients with SCI (diagnosed via imaging and clinical symptoms) admitted to our hospital between January 2020 and December 2022 were selected as the study participants. The patients were randomly divided into two groups: the MBSR (observation) group and the control group. The observation group received MBSR therapy and routine nursing, and the control group received music training therapy and routine nursing. The Pittsburgh Sleep Quality Index (PSQI) was used to evaluate sleep quality, and the perceived stress score was used to evaluate stress experienced by the patients at three timepoints: before intervention, 4 weeks and 8weeks after intervention.</p></div><div><h3>Results</h3><p>Compared with before intervention, the PSQI scores of both the control group and intervention group participants significantly decreased after intervention(<em>P</em> < 0.01). Compared with the 4 weeks after intervention, the PSQI scores of both groups of participants decreased in the 8 weeks after intervention(<em>P</em> < 0.01). There was a significant difference in PSQI scores between the two groups of participants at 4 and 8 weeks after intervention(<em>P</em> < 0.01). Compared with before intervention, the average perceived stress score of both the control group and intervention group participants significantly decreased after intervention(<em>P</em> < 0.05). Compared with the 4 weeks after intervention, the average perceived stress score of both groups of participants decreased in the 8 weeks after intervention(<em>P</em> < 0.01). There was a significant difference in average perceived stress score between the two groups of participants at 4(<em>P</em> < 0.05) and 8 weeks(<em>P</em> < 0.01) after intervention(<em>P</em> < 0.01).</p></div><div><h3>Conclusion</h3><p>The use of MBSR therapy could effectively improve patient sleep quality and reduce perceived stress.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 5","pages":"Article 103037"},"PeriodicalIF":1.9,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142006797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-24DOI: 10.1016/j.explore.2024.103036
Marjorie Woollacott
Increasing numbers of research studies have offered evidence regarding awareness of verified events during near-death experiences (NDEs) occurring during cardiac arrest and severely impaired brain function. The prevalence of patients reporting core NDEs under these conditions is reported as 10–12 %. One question that is often asked is why this percentage is low. Though it may be hypothesized that NDEs are limited to this low percentage of patients, it is also possible that more patients experience an NDE, but that memory is impaired sufficiently such that the NDE is not recalled. In this article I present a detailed and extensively verified case study of a woman, Stephanie Arnold, who experienced an NDE during the birth of her second child when she was 41 years old. The data provide evidence that supports the hypotheses 1) that during cardiac arrest an NDE may occur, but not be remembered until hypnotic regression therapy reveals extensive details of the events that could not have been perceived with the five senses, both in the operating room and elsewhere during resuscitation. 2) that there may also be pre-cognition of the events leading to the cardiac arrest, reported in clear detail, and 3) that NDEs lead to a fundamental transformation in an individual's understanding of the nature of consciousness, their quest for meaning and purpose, their concern for others, and their appreciation of life.
越来越多的研究提供了证据,证明在心脏骤停和脑功能严重受损的濒死体验(NDE)过程中,患者能够意识到已证实的事件。据报道,在这些情况下报告核心濒死体验的患者比例为 10-12%。人们经常问的一个问题是,为什么这个比例很低。虽然可以假设 NDE 仅限于这一低比例的患者,但也有可能有更多的患者经历过 NDE,但由于记忆力受损而无法回忆起 NDE。在这篇文章中,我介绍了一个详细且经过广泛验证的案例研究,研究对象是一位名叫斯蒂芬妮-阿诺德的女性,她在 41 岁时生第二个孩子时经历了一次 NDE。这些数据提供了支持以下假设的证据:1)在心脏骤停期间,可能会发生 NDE,但直到催眠回归疗法揭示了在手术室和复苏期间五官无法感知的事件的大量细节后,才会被记起。2) 对导致心脏骤停的事件也可能有预先认知,并有清晰的细节报告;以及 3) NDE 会导致个人对意识本质的理解、对意义和目的的追求、对他人的关心以及对生命的珍惜发生根本性转变。
{"title":"Near-death experience: memory recovery during hypnosis","authors":"Marjorie Woollacott","doi":"10.1016/j.explore.2024.103036","DOIUrl":"10.1016/j.explore.2024.103036","url":null,"abstract":"<div><p>Increasing numbers of research studies have offered evidence regarding awareness of verified events during near-death experiences (NDEs) occurring during cardiac arrest and severely impaired brain function. The prevalence of patients reporting core NDEs under these conditions is reported as 10–12 %. One question that is often asked is why this percentage is low. Though it may be hypothesized that NDEs are limited to this low percentage of patients, it is also possible that more patients experience an NDE, but that memory is impaired sufficiently such that the NDE is not recalled. In this article I present a detailed and extensively verified case study of a woman, Stephanie Arnold, who experienced an NDE during the birth of her second child when she was 41 years old. The data provide evidence that supports the hypotheses 1) that during cardiac arrest an NDE may occur, but not be remembered until hypnotic regression therapy reveals extensive details of the events that could not have been perceived with the five senses, both in the operating room and elsewhere during resuscitation. 2) that there may also be pre-cognition of the events leading to the cardiac arrest, reported in clear detail, and 3) that NDEs lead to a fundamental transformation in an individual's understanding of the nature of consciousness, their quest for meaning and purpose, their concern for others, and their appreciation of life.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":"20 6","pages":"Article 103036"},"PeriodicalIF":1.9,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141784567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}